In Vitro Fertilization (IVF) Market - Global Industry Analysis

In Vitro Fertilization (IVF) Market by Type (Fresh Donor, Frozen Donor, Fresh Non-Donor, and Frozen Non-Donor), By End Users (Hospitals, Cryobanks, and Fertility Clinics), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028

Published Date: 28-Mar-2022 Category: Pharmaceutical Report Format : PDF Pages: 144 Report Code: ZMR-964 Status : Published

The size of the global in vitro fertilization (IVF) market is expected to grow at the rate of 9.85% CAGR during the forecast period from USD 650 million in 2021 to approximately USD 1028 million by 2028.

Description

In Vitro Fertilization (IVF) Market: Industry Prospective

The size of the global in vitro fertilization (IVF) market is expected to grow at the rate of 9.85% CAGR during the forecast period from USD 650 million in 2021 to approximately USD 1028 million by 2028. This report discusses market research on the in vitro fertilization (IVF) market, its market growth factors, and its challenges. The report also talks about the opportunities available to stakeholders and potential investors for the in vitro fertilization (IVF) market, discussing the recent changes due to the pandemic.

In Vitro Fertilization (IVF) Market: Overview

In vitro fertilization (IVF) is a form of assisted reproductive technology (ART) that involves the use of a mix of drugs and surgical procedures. In an infertile couple, IVF therapy aids embryo development and implantation. IVF is a method of fertilization in which eggs are extracted, a sperm sample is obtained, and the egg and sperm are manually combined in a laboratory. Every year, nearly half a million infants are born through IVF or other artificial insemination treatments as a result of the growing use of technology. As a result, the rising popularity of IVF and ICSI therapy is expected to rise in vitro fertilization (IVF) treatment adoption throughout the projection period.

COVID-19 Impact:

The worldwide stoppage of in vitro fertilization therapy was precipitated by the COVID-19 pandemic, which had a significant impact on women having IVF operations. Only 5 lakh persons in India undertake IVF/intrauterine insemination (IUI) treatments each year, even though 30 lakh people want IVF every year. The number of patients conducting IVF cycles dropped by 90 percent during the COVID-19 epidemic. COVID-19's spread has influenced fertility clinics, resulting in the cancellation of IVF treatments, as well as fertility decisions among couples who had chosen IVF treatment before the pandemic.

Global In Vitro Fertilization (IVF) Market

In Vitro Fertilization (IVF) Market: Growth Drivers

The increased average age of first-time mothers drives the market growth

In recent decades, it has been observed that women are delaying their pregnancy post the age of 30. Medically it is believed that chances of conceiving post 32 years of age drop by 50% in women, resulting in complications. The median age for first-time mothers has drastically increased, increasing the risk of infertility. This delay is observed due to late marriages, and couples who focus more on careers rather than extending their families. Given the scenario and the average fertility rate drop by around 2.5%, the global in vitro fertilization (IVF) market is expected to grow.

In Vitro Fertilization (IVF) Market: Restraints

Costly procedures to restrict the market growth

An average in vitro fertilization (IVF) procedure can cost anywhere between USD 13,000 to USD 18,000, excluding medications. Added to the pre and post-care expenses, genetic testing, surgical procedures, and medications, it rises to around USD 24,000 to USD 28,000. Several potential patients cannot afford such high charges, and thus do not opt for IVF treatments. This leaves out a huge market unexplored, which has potential for the global in vitro fertilization (IVF) market if the treatment costs are reduced.

In Vitro Fertilization (IVF) Market: Opportunities

Improvement in Cryogenic Technology to provide growth opportunities

In vitro fertilization (IVF) requires to cryopreserve technologies to preserve tissues and cell types for assistance in artificial reproductions. The drop in female fertility rate has resulted in increased demand for the preservation of sperm, oocytes, ovarian tissues, embryos as well as egg vitrification. The developments in cryogenics can be harvested positively to develop more techniques and procedures for IVF treatments, thus providing new opportunities and avenues for the global in vitro fertilization (IVF) market.

In Vitro Fertilization (IVF) Market: Challenges

Lack of awareness and reduced efficiency in elderly patients pose a challenge

Developing countries have a lower awareness regarding in vitro fertilization (IVF) treatments. Given the cultural and social prejudices in some regions, couples or single parents opting for IVF are looked down upon. These social implications affect the global market adversely. Secondly, as the age of patients increase, the success rate of IVF decreases. Given the fact that people are opting for pregnancy at a later stage, increasing their age, and adding to complications, success cannot be guaranteed. This hinders the growth of the global in vitro fertilization (IVF) market.

In Vitro Fertilization (IVF) Market: Segmentation Analysis

The market is divided into two categories, namely types, end-users, and regions.

Depending on end-users the market is divided into hospitals, fertility clinics, and cryobanks. The fertility clinical institutions are expected to grow compared to other segments, given the requirement for fertility research. Patients generally opt for IVF treatments in infertility clinics rather than generalized hospitals. The cryobanks segment is also expected to witness growth during the projection period. Development in cryopreservation will boost the scope for this segment.

Depending on the types, the market can be divided into fresh donors, frozen donors, fresh non-donor, and frozen non-donor. The fresh non-donor segment is expected to capture the market share, due to higher success rates, easy process, and also due to improved embryo production. This segment also requires less preservation and thus the charges are less in comparison to the rest.

Recent Developments

  • In 2019, to reduce the risk of miscarriage during in vitro fertilization (IVF) treatments, a new technology for embryo screening was developed by Monash IVF.
  • In 2019, Shady Grove Fertility opened a full-service in vitro fertilization (IVF) center in Florida that provides affordable and better quality IVF treatments to regional clients.

In Vitro Fertilization (IVF) Market: Regional Landscape

Europe has a strong position in the in vitro fertilization business. This is due to an increase in the prevalence of infertility in the region, as well as the growing popularity of IVF therapy. On the other hand, due to the high cost of ICSI and IVF treatment in North America, the market will continue to rise steadily. As a result, people in the United States are opting for IVF treatment in other nations due to reduced prices.

Followed by Europe, Asia Pacific sees significant development in the global in vitro fertilization (IVF) market. Significant growth in medical tourism, increased knowledge of in vitro fertilization processes, decreased IVF treatment procedures, expanding fertility clinics in the region, rising healthcare expenditures, and growing acceptance of assisted reproductive technologies in emerging countries are fueling the growth in the Asia Pacific region.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

In Vitro Fertilization (IVF) Market: Competitive Landscape

Several clinics and institutions are operating in the global in vitro fertilization (IVF) market, some of the prominent ones being ZEISS Group, Cooper Companies Inc., Esco Micro Pte. Ltd., The Baker Company Inc., Cook Group, Hamilton Thorne Ltd., and Kitazzto Corporation.

The global in vitro fertilization (IVF) market is segmented as follows:

By Type

  • Frozen Donor
  • Fresh Non Donor
  • Fresh Donor
  • Frozen Non Donor

By End User

  • Hospitals
  • Cryobanks
  • Fertility Clinics

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global in vitro fertilization (IVF) market, 2017 - 2024(USD Million)
    • 2.2. Global in vitro fertilization (IVF) market: snapshot
  •  
  • Chapter 3. In Vitro Fertilization (IVF) Market- Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Global In Vitro Fertilization (IVF) market drivers: impact analysis
      • 3.2.2. Delayed pregnancies in women and decreasing Fertility Rates
      • 3.2.3. Rising male infertility and changing lifestyle pattern
      • 3.2.4. Growing public awareness about infertility and the available treatment options
      • 3.2.5. Government initiatives to promote IVF treatments
      • 3.2.6. Introduction of new and advanced products
      • 3.2.7. Rise in disposable income
    • 3.3. Market Restraints
      • 3.3.1. Global in vitro fertilization (IVF) market restraints: impact analysis
      • 3.3.2. Low success rate and high cost of the IVF treatment
      • 3.3.3. Multiple pregnancies
      • 3.3.4. Restrictive regulations and ethical concerns
    • 3.4. Opportunities
      • 3.4.1. Rising research & development activity for in vitro fertilization (IVF) products
      • 3.4.2. Fertility Tourism
      • 3.4.3. Growing number of fertility clinics
    • 3.5. Porter's five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis, by product type segment
      • 3.6.2. Market attractiveness analysis, by cycle type segment
      • 3.6.3. Market attractiveness analysis, by regional segment
  •  
  • Chapter 4. Global In Vitro Fertilization (IVF) Market- Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global in vitro fertilization (IVF) market: company market share, 2017
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New therapy launch
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  •  
  • Chapter 5. Global In Vitro Fertilization (IVF) Market- Product Type Segment Analysis
    • 5.1. Global In Vitro Fertilization (IVF) market: product overview
      • 5.1.1. Global In Vitro Fertilization (IVF) market revenue share, by product type, 2017 and 2024
    • 5.2. Instruments
      • 5.2.1. Global In Vitro Fertilization (IVF) market for Instruments, 2017 - 2024(USD Million)
      • 5.2.2. Cryosystem, In Vitro Fertilization (IVF) market for Instruments, 2017 - 2024(USD Million)
      • 5.2.3. Incubators, In Vitro Fertilization (IVF) market for Instruments, 2017 - 2024 (USD Million)
      • 5.2.4. Imaging system, In Vitro Fertilization (IVF) market for Instruments, 2017 - 2024 (USD Million)
      • 5.2.5. Ovum Aspiration Pump, In Vitro Fertilization (IVF) market for Instruments, 2017 - 2024 (USD Million)
      • 5.2.6. Cabinet, In Vitro Fertilization (IVF) market for Instruments, 2017 - 2024 (USD Million)
      • 5.2.7. Micro Manipulator System, In Vitro Fertilization (IVF) market for Instruments, 2017 - 2024 (USD Million)
      • 5.2.8. Sperm Separation System, In Vitro Fertilization (IVF) market for Instruments, 2017 - 2024 (USD Million)
      • 5.2.9. Disposables and Accessories, In Vitro Fertilization (IVF) market for Instruments, 2017 - 2024 (USD Million)
      • 5.2.10. Others ,In Vitro Fertilization (IVF) market for Instruments, 2017 - 2024(USD Million)
    • 5.3. Reagent & Media
      • 5.3.1. Global In Vitro Fertilization (IVF) market for Reagent & Media, 2017 - 2024 (USD Million)
      • 5.3.2. Cryopreservation Media, In Vitro Fertilization (IVF) market for Reagent & Media, 2017 - 2024 (USD Million)
      • 5.3.3. Ovum Processing Media , In Vitro Fertilization (IVF) market for Reagent & Media, 2017 - 2024 (USD Million)
      • 5.3.4. Semen Processing Media , In Vitro Fertilization (IVF) market for Reagent & Media, 2017 - 2024 (USD Million)
      • 5.3.5. Embryo Culture Media , In Vitro Fertilization (IVF) market for Reagent & Media, 2017 - 2024 (USD Million)
  •  
  • Chapter 6. Global In Vitro Fertilization (IVF) Market- Cycle type Segment Analysis
    • 6.1. Global In Vitro Fertilization (IVF) market: form type overview
      • 6.1.1. Global In Vitro Fertilization (IVF) market revenue share, by cycle type, 2017 and 2024
    • 6.2. Fresh Donor IVF Cycles
      • 6.2.1. Global In Vitro Fertilization (IVF) market for Fresh Donor IVF Cycles, 2017 - 2024 (USD Million)
    • 6.3. Fresh Non-donor IVF Cycles
      • 6.3.1. Global In Vitro Fertilization (IVF) market for Fresh Non-donor IVF Cycles, 2017 - 2024 (USD Million)
    • 6.4. Frozen Donor IVF Cycles
      • 6.4.1. Global In Vitro Fertilization (IVF) market for Frozen Donor IVF Cycles ,2017 - 2024 (USD Million)
    • 6.5. Frozen Non-donor IVF Cycles
      • 6.5.1. Global In Vitro Fertilization (IVF) market for Frozen Non-Donor IVF Cycles ,2017 - 2024 (USD Million)
  •  
  • Chapter 7. Global In Vitro Fertilization (IVF) Market- Regional Segment Analysis
    • 7.1. Global In Vitro Fertilization (IVF) market: regional overview
      • 7.1.1. Global In Vitro Fertilization (IVF) market revenue share, by region, 2017 and 2024
    • 7.2. North America
      • 7.2.1. North America In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
      • 7.2.2. North America In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
      • 7.2.3. U.S.
        • 7.2.3.1. U.S. In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
        • 7.2.3.2. U.S. In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
      • 7.2.4. Rest of North America
        • 7.2.4.1. Rest of North America In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
        • 7.2.4.2. Rest of North America In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
    • 7.3. Europe
      • 7.3.1. Europe In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
      • 7.3.2. Europe In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
      • 7.3.3. U.K.
        • 7.3.3.1. U.K. In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024 (USD Million)
        • 7.3.3.2. U.K. In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024 (USD Million)
      • 7.3.4. Germany
        • 7.3.4.1. Germany In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
        • 7.3.4.2. Germany In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
      • 7.3.5. France
        • 7.3.5.1. France In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
        • 7.3.5.2. France In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
      • 7.3.6. Italy
        • 7.3.6.1. Italy In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
        • 7.3.6.2. Italy In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
      • 7.3.7. Spain
        • 7.3.7.1. Spain In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
        • 7.3.7.2. Spain In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
      • 7.3.8. Rest of Europe
        • 7.3.8.1. Rest of Europe In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
        • 7.3.8.2. Rest of Europe In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024 (USD Million)
      • 7.4.2. Asia Pacific In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
      • 7.4.3. China
        • 7.4.3.1. China In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
        • 7.4.3.2. China In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
      • 7.4.4. Japan
        • 7.4.4.1. Japan In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
        • 7.4.4.2. Japan In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
      • 7.4.5. India
        • 7.4.5.1. India In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
        • 7.4.5.2. India In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
      • 7.4.6. Southeast Asia
        • 7.4.6.1. Southeast Asia In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
        • 7.4.6.2. Southeast Asia In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
      • 7.4.7. Rest of Asia Pacific
        • 7.4.7.1. Rest of Asia Pacific In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
        • 7.4.7.2. Rest of Asia Pacific In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
    • 7.5. Latin America
      • 7.5.1. Latin America In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
      • 7.5.2. Latin America In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
      • 7.5.3. Brazil
        • 7.5.3.1. Brazil In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
        • 7.5.3.2. Brazil In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
      • 7.5.4. Rest of Latin America
        • 7.5.4.1. Rest of Latin America In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
        • 7.5.4.2. Rest of Latin America In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
    • 7.6. Middle East and Africa
      • 7.6.1. Middle East and Africa In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
      • 7.6.2. Middle East and Africa In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
      • 7.6.3. GCC Countries
        • 7.6.3.1. GCC Countries In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
        • 7.6.3.2. GCC Countries In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
      • 7.6.4. Rest of Middle East and Africa
        • 7.6.4.1. Rest of Middle East and Africa In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
        • 7.6.4.2. Rest of Middle East and Africa In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
  •  
  • Chapter 8. Company Profile
    • 8.1. CooperSurgical, Inc.
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product portfolio
      • 8.1.4. Business strategy
      • 8.1.5. Recent developments
    • 8.2. Thermo Fisher Scientific
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product portfolio
      • 8.2.4. Business strategy
      • 8.2.5. Recent developments
    • 8.3. Vitrolife, Cook
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product portfolio
      • 8.3.4. Business strategy
      • 8.3.5. Recent developments
    • 8.4. Irvine Scientific
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product portfolio
      • 8.4.4. Business strategy
      • 8.4.5. Recent developments
    • 8.5. EMD Serono, Inc.
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product portfolio
      • 8.5.4. Business strategy
      • 8.5.5. Recent developments
    • 8.6. Genea Limited
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product portfolio
      • 8.6.4. Business strategy
      • 8.6.5. Recent developments
    • 8.7. Esco Group
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Product portfolio
      • 8.7.4. Business strategy
      • 8.7.5. Recent developments
    • 8.8. Rocket Medical plc.
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Product portfolio
      • 8.8.4. Business strategy
      • 8.8.5. Recent developments
    • 8.9. Nidacon International AB
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Product portfolio
      • 8.9.4. Business strategy
      • 8.9.5. Recent developments
    • 8.10. Lotus Bio
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Product portfolio
      • 8.10.4. Business strategy
      • 8.10.5. Recent developments
    • 8.11. Eppendorf AG
      • 8.11.1. Overview
      • 8.11.2. Financials
      • 8.11.3. Product portfolio
      • 8.11.4. Business strategy
      • 8.11.5. Recent developments
    • 8.12. Okolab Srl
      • 8.12.1. Overview
      • 8.12.2. Financials
      • 8.12.3. Product portfolio
      • 8.12.4. Business strategy
      • 8.12.5. Recent developments
    • 8.13. IKS International
      • 8.13.1. Overview
      • 8.13.2. Financials
      • 8.13.3. Product portfolio
      • 8.13.4. Business strategy
      • 8.13.5. Recent developments
    • 8.14. HUNTER SCIENTIFIC LIMITED
      • 8.14.1. Overview
      • 8.14.2. Financials
      • 8.14.3. Product portfolio
      • 8.14.4. Business strategy
      • 8.14.5. Recent developments
    • 8.15. LABOTECT GMBH
      • 8.15.1. Overview
      • 8.15.2. Financials
      • 8.15.3. Product portfolio
      • 8.15.4. Business strategy
      • 8.15.5. Recent developments
    • 8.16. Olympus Corporation
      • 8.16.1. Overview
      • 8.16.2. Financials
      • 8.16.3. Product portfolio
      • 8.16.4. Business strategy
      • 8.16.5. Recent developments
    • 8.17. RI.MOS. srl
      • 8.17.1. Overview
      • 8.17.2. Financials
      • 8.17.3. Product portfolio
      • 8.17.4. Business strategy
      • 8.17.5. Recent developments

Table Of Figures

List of Figures 

1. Market research process
2. Market research methodology
3. Global In Vitro Fertilization (IVF) market revenue, 2017 – 2024(USD Million) 
4. Porter’s five forces analysis
5. In Vitro Fertilization (IVF) market attractiveness analysis, by product type segment
6. In Vitro Fertilization (IVF) market attractiveness analysis, by cycle type segment
7. In Vitro Fertilization (IVF) market: market attractiveness analysis, by regional segment
8. Company market share analysis, 2017
9. Global In Vitro Fertilization (IVF) market revenue share by product type, 2017 and 2024
10. Global In Vitro Fertilization (IVF) market revenue share by Instrument, 2017 and 2024
11. Cryosystem, In Vitro Fertilization (IVF) market revenue share by Instrument type, 2017 and 2024
12. Incubators, In Vitro Fertilization (IVF) market revenue share by Instrument type, 2017 and 2024
13. Imaging system, In Vitro Fertilization (IVF) market revenue share by Instrument type, 2017 and 2024
14. Ovum Aspiration Pump, In Vitro Fertilization (IVF) market revenue share by Instrument type, 2017 and 2024
15. Cabinet, In Vitro Fertilization (IVF) market revenue share by Instrument type, 2017 and 2024
16. Micro Manipulator System, In Vitro Fertilization (IVF) market revenue share by Instrument type, 2017 and 2024
17. Sperm Separation System, In Vitro Fertilization (IVF) market revenue share by Instrument type, 2017 and 2024
18. Disposables and Accessories, In Vitro Fertilization (IVF) market revenue share by Instrument type, 2017 and 2024
19. Other instruments, In Vitro Fertilization (IVF) market revenue share by Instrument type, 2017 and 2024
20. Global  In Vitro Fertilization (IVF) market revenue share by Reagent & Media, 2017 and 2024
21. Cryopreservation Media, In Vitro Fertilization (IVF) market revenue share by Reagent & Media, 2017 and 2024
22. Ovum Processing Media, In Vitro Fertilization (IVF) market revenue share by Reagent & Media, 2017 and 2024
23. Semen Processing Media, In Vitro Fertilization (IVF) market revenue share by Reagent & Media, 2017 and 2024
24. Embryo Culture Media, In Vitro Fertilization (IVF) market revenue share by Reagent & Media, 2017 and 2024
25. Global In Vitro Fertilization (IVF) market revenue share by cycle type, 2017 and 2024
26. Fresh Donor IVF Cycles, In Vitro Fertilization (IVF) market revenue share by cycle type, 2017 and 2024
27. Fresh Non-donor IVF Cycles, In Vitro Fertilization (IVF) market revenue share by cycle type, 2017 and 2024
28. Frozen Donor IVF Cycles, In Vitro Fertilization (IVF) market revenue share by cycle type, 2017 and 2024
29. Frozen Non-donor IVF Cycles, In Vitro Fertilization (IVF) market revenue share by cycle type, 2017 and 2024


Table Of Tables

List of Tables

1. In Vitro Fertilization (IVF) market: market snapshot                                                                                                                     2. Drivers of global In Vitro Fertilization (IVF) market: impact analysis 
3. Restraints of global In Vitro Fertilization (IVF) market: impact analysis  
4. North America In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
5. North America In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
6. U.S. In Vitro Fertilization (IVF)market revenue, by product type, 2017 – 2024(USD Million)
7. U.S. In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
8. Rest of North America In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
9. Rest of North America In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
10. Europe In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
11. Europe In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
12. U.K. In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
13. U.K. In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
14. Germany In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
15. Germany In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
16. France In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
17. France In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
18. Italy In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
19. Italy In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
20. Spain In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
21. Spain In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
22. Rest of Europe In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
23. Rest of Europe In Vitro Fertilization (IVF) market revenue, by cycle type area, 2017 – 2024(USD Million)
24. Asia Pacific In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
25. Asia Pacific In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
26. China In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
27. China In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
28. Japan In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
29. Japan In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
30. India In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
31. India In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
32. Southeast Asia In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
33. Southeast Asia In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
34. Rest of Asia Pacific In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
35. Rest of Asia Pacific In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
36. Latin America In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
37. Latin America In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
38. Brazil In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
39. Brazil In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
40. Rest of Latin America In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
41. Rest of Latin America In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
42. Middle East and Africa In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
43. Middle East and Africa In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
44. GCC Countries In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
45. GCC Countries In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
46. South Africa In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
47. South Africa In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
48. Rest of Middle East and Africa In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
49. Rest of Middle East and Africa In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)

Methodology

Free Analysis

In vitro fertilization is the technique of assisted reproduction, where male sperm and female egg is fertilized by placing together in a plastic dish or cell culture. The fertilized egg is implanted in the uterus to make an effort to attach and develop the egg inside the female body. The egg, embryos, or sperms are preserved, frozen, and are stored for later use. In 1978, the first IVF baby, Louise Brown was born in the United Kingdom. The in vitro fertilization technique was primarily developed to treat infertility caused by damaged or blocked of fallopian tubes, but now it is used to treat a wide range of infertility problems. 

The global in vitro fertilization (IVF) market is segmented as product type, cycle type, and by geography. Based on product type, the in vitro fertilization (IVF) market is segmented into instruments and reagent & media. The instruments segment is further sub-segmented into cryosystem, incubators, imaging system, ovum aspiration pump, cabinet, micromanipulator system, sperm separation system, disposables and accessories, and other instruments. The reagent & media segment is again segmented into cryopreservation media, ovum processing media, semen processing media, and embryo culture media. On the basis of cycle type, the in vitro fertilization (IVF) market is segmented into fresh donor IVF cycles, fresh non-donor IVF cycles, frozen donor IVF cycles, and frozen non-donor IVF cycles. 

Global In Vitro Fertilization (IVF) Market

Asia Pacific held a dominant share of the global market for in vitro fertilization (IVF) in the 2017 and is projected to continue with its regional supremacy over the forthcoming years as well. The increasing availability and accessibility of healthcare facilities, growing research and development expenditure, increasing infertility rate, rising prevalence of PCOS, and continuous growth in fertility tourism is expected to propel the growth of in vitro fertilization (IVF) market in the Asia Pacific. Followed by the Asia Pacific is Europe which anticipates holding the second largest share of the global market. The high awareness about the in vitro fertilization (IVF) products, ease of reimbursement policies, and easy availability of in vitro fertilization (IVF) products in the region are significantly contributing towards the growth of the market in Europe. 

Some of the key players in the in vitro fertilization (IVF) market are Cooper Surgical, Inc., Thermo Fisher Scientific, Vitrolife, Cook, Irvine Scientific, EMD Serono, Inc., Genea Limited, Esco Group, Rocket Medical plc, Nidacon International AB, Lotus Bio, Eppendorf AG, Okolab Srl, IKS International, Hunter Scientific Limited, Labotect GmbH, Olympus Corporation, and RI.MOS. Srl.

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

The global median age for women opting for reproduction is increasing. Added to this the technologies for cryopreservation are improving IVF services. Both of these factors help the global in vitro fertilization (IVF) market grow in the coming years.

According to the report by Zion Market Research, the size of the global in vitro fertilization (IVF) market is expected to grow at a rate (CAGR) of 9.85%, from USD 650 million in 2021 to attain a value of USD 1028 million by 2028.

Europe has a strong position in the in vitro fertilization business. This is due to an increase in the prevalence of infertility in the region, as well as the growing popularity of IVF therapy. On the other hand, due to the high cost of ICSI and IVF treatment in North America, the market will continue to rise steadily. As a result, people in the United States are opting for IVF treatment in other nations due to reduced prices.

ZEISS Group, Cooper Companies Inc., Esco Micro Pte. Ltd., The Baker Company Inc., Cook Group, Hamilton Thorne Ltd. and Kitazzto Corporation are some prominent companies in the global in vitro fertilization (IVF) market.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed